Health Populi

OCTOBER 28, 2019

rank prescription drugs, lab tests, emergency room visits, dental and vision care, preventive services, chronic disease management and mental health care as the “most essential” health care services, according to the 2019 Survey of America’s Patients conducted by The Physicians Foundation. People in the U.S.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Henry Kotula

JULY 1, 2019

Thirty-eight percent of large employers offered a worksite clinic in 2019, up from 27 percent in 2014. The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. WHAT ELSE YOU SHOULD KNOW.

Life Science 32

Life Science Pharmaceuticals Mental health Telemedicine 32

Health Populi

OCTOBER 8, 2019

In “Waste in the US Health Care System,” a team from Humana and the Univrsity of Pittsburgh recalibrated the previous finding of 30% of wasted spending to the 25%, which equates to a waste-range of $760 bn to $935 bn. That’s the Holy Grail and vision in my book, HealthConsuming: From Health Consumer to Health Citizen.

Pharmaceuticals 271

Pharmaceuticals Medicare Life Science Health Policy 271

Health Populi

MARCH 28, 2022

I wrote about the company’s approach to food-as-medicine here in Health Populi in 2019 when Kroger Health began to message and market itself as a trusted health and wellness destination, Health Populi’s Hot Points: Over the 3 decades I’ve advised health care stakeholders across the ecosystem, I’ve benefited from working with (..)

Life Science 280

Life Science mHealth Primary Care Pharmaceuticals 280

Health Populi

JANUARY 18, 2021

While Peloton was a punchline in some peoples’ jokes at the 2019 holiday season ( see here ), the company had an enviable growing waiting list in 2020 — the right thing at the right time.

Digital Health 194

Digital Health Public Health Life Science Patient Experience 194

Health Populi

JANUARY 31, 2025

How will we know if the life sciences sector is advancing in 2025? This is the question asked at the start of the report, a Research Brief: 2025 Indicators of Progress for the Life Sciences Sector, from the IQVIA Institute for Human Data Science (IQVIA). We start with the state of trust held by U.S.

Life Science 177

Life Science Public Health Primary Care Pharmaceuticals 177

Health Populi

MARCH 6, 2019

There’s little Americans, by political party, agree upon in 2019. The Kaiser Family Foundation has been tracking this topic for a few years, and this month, their March 2019 Health Tracking Poll shows vast majorities of Democrats, Independents and Republicans all share these sentiments.

Pharmaceuticals 149

Pharmaceuticals Medicare Life Science BioTech 149

Health Populi

JUNE 18, 2020

A Kaiser Family Foundation poll covered here in Health Populi demonstrated support across party ID back in October 2019. The Gallup-West Health Poll finds similar massive support for government negotiation specifically for COVID-19 treatment pricing, shown in the third table. Gallup and West Health polled 1,016 U.S.

BioTech 199

BioTech Medicare Life Science Telehealth 199

Health Populi

FEBRUARY 22, 2021

Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Interestingly, these are two of the most prominent life science companies that have been part of Operation Warp Speed to accelerate the development of COVID-19 vaccines.

Life Science 386

Life Science Pharmaceuticals Public Health BioTech 386

Health Populi

FEBRUARY 17, 2025

Eroding trust in government, media, and public health officials was already a dynamic in late 2019-early 2020, as I discussed here in Health Populi in the context of the 2020 Edelman Trust Barometer. public that would connect with people. That year, just prior to the pandemic emerging in the U.S.,

Public Health 177

Public Health Life Science Patient Experience Connected Health 177

Health Populi

FEBRUARY 4, 2020

voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Last year, IQVIA estimated a median price for new oncologics in 2019 was $149,000. Few issues unite U.S.

Pharmaceuticals 207

Pharmaceuticals Medicare Leadership Life Science 207

Health Populi

MAY 19, 2019

Health care and the economy are, in fact, intimately tied in every American’s personal household economy I assert in my book, HealthConsuming: From Health Consumer to Health Citizen. Technology, biotech, hospitals, and life science companies would be the health care improvers, most Americans told RealClear pollsters.

Life Science 159

Life Science BioTech Medicare Medical Billing 159